These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37492582)

  • 1. Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement.
    Chen G; Feng L
    Front Immunol; 2023; 14():1166265. PubMed ID: 37492582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus.
    Okedere TA; Asaleye CM; Ayoola OO; Kolawole BA; Salako AA; Idowu BM; Onigbinde SO; Oguntade BO
    Cent European J Urol; 2023; 76(3):199-206. PubMed ID: 38045784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of and associated factors for prostate calcification in ≥40-year-old males with benign prostatic enlargement].
    Zhang XM; Xiao L; Cheng ZS; Lin CM; Zhang L; Zhou J; Hao ZY; Liang CZ
    Zhonghua Nan Ke Xue; 2022 Jul; 28(7):579-584. PubMed ID: 37556213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study.
    Lin YH; Hou CP; Chen TH; Juang HH; Chang PL; Yang PS; Lin YS; Chen CL; Tsui KH
    Clin Interv Aging; 2017; 12():535-541. PubMed ID: 28356725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus.
    Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B
    Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic enlargement is not associated with diabetes: a population-based study.
    Chiu YL; Kao S; Lin HC; Liu SP; Huang CY
    Andrology; 2015 Sep; 3(5):933-6. PubMed ID: 26216209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity in benign prostatic enlargement: A cross-sectional study comparing sonographic and anthropometric indices of adiposity in a tertiary hospital in Southwestern Nigeria.
    Asaleye CM; Omisore AD; Onigbinde SO; David RA
    Niger J Clin Pract; 2019 Nov; 22(11):1600-1605. PubMed ID: 31719283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of causes of failure of medical treatment in patients undergoing surgery for benign prostate enlargement.
    Anand A; Gupta NP; Dogra PN; Seth A
    Urologia; 2022 Nov; 89(4):553-558. PubMed ID: 34965812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lymphocyte-to-Monocyte Ratio with Benign Prostatic Hyperplasia: A Propensity Score-Matched Analysis.
    Kang JY; Choi JD; Cho JM; Yoo TK; Park YW; Lee JH
    Urol Int; 2021; 105(9-10):811-816. PubMed ID: 33508844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.
    Qu X; Huang Z; Meng X; Zhang X; Dong L; Zhao X
    Int Urol Nephrol; 2014 Mar; 46(3):499-504. PubMed ID: 24022843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and benign prostatic enlargement: a large observational study in China.
    Xie LP; Bai Y; Zhang XZ; Zheng XY; Yao KS; Xu L; Zeegers MP
    Urology; 2007 Apr; 69(4):680-4. PubMed ID: 17445651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate volume and age are predictors of energy delivery using the CoreTherm Concept in patients with LUTS/BPO: a study on thermal dose.
    Stenmark F; Brudin L; Kjölhede H; Peeker R; Stranne J
    Scand J Urol; 2020 Jun; 54(3):248-252. PubMed ID: 32401123
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can second to fourth finger ratio play a role in determining the risk of benign prostatic enlargement.
    Toprak T; Arslan U; Kutluhan MA; Sahin A; Akgul K; Sahan A; Verit A
    Andrologia; 2020 May; 52(4):e13529. PubMed ID: 32039514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and potential role of prostate microbiota.
    Okada K; Takezawa K; Tsujimura G; Imanaka T; Kuribayashi S; Ueda N; Hatano K; Fukuhara S; Kiuchi H; Fujita K; Motooka D; Nakamura S; Koyama Y; Shimada S; Nonomura N
    Front Cell Infect Microbiol; 2022; 12():1048319. PubMed ID: 36569206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical Prostatic Protrusion as a Predicting Factor for the Adverse Clinical Outcome in Patients With Symptomatic Benign Prostatic Enlargement Treated With Dutasteride.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Taniguchi H; Yanishi M; Komai Y; Yasuda K; Sugi M; Matsuda T
    Urology; 2016 May; 91():154-7. PubMed ID: 26826590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement.
    Onigbinde SO; Asaleye CM; Salako AA; Idowu BM; Onigbinde AO; Laoye A
    Prostate Int; 2023 Mar; 11(1):46-50. PubMed ID: 36910898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption, Safety, and Retreatment Rates of Prostatic Urethral Lift for Benign Prostatic Enlargement.
    Gaffney CD; Basourakos SP; Al Hussein Al Awamlh B; Wu X; Cai PY; Hijaz A; Jaeger I; Lee RK; Shoag JE
    J Urol; 2021 Aug; 206(2):409-415. PubMed ID: 33793296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.